{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:44:19Z","timestamp":1791398659533,"version":"4.3.3"},"reference-count":37,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Epithelial barrier dysfunction is increasingly recognized as a central pathogenic mechanism in chronic inflammatory airway diseases characterized by type 2 immune responses. Chronic rhinosinusitis with nasal polyps (CRSwNP) represents a paradigmatic condition in which structural epithelial alterations, impaired barrier integrity, and sustained release of epithelial-derived alarmins interact with innate and adaptive immune pathways to drive persistent inflammation and tissue remodeling. In this context, understanding disease heterogeneity requires tools capable of capturing cellular and immunological complexity beyond purely molecular or symptom-based classifications. Nasal cytology is a standardized, minimally invasive, and repeatable technique that provides direct in vivo assessment of epithelial morphology and inflammatory cell infiltrates at the mucosal surface. By identifying distinct cytological patterns, including eosinophil-dominant, mast cell-rich, and mixed inflammatory signatures, nasal cytology reflects the underlying immunopathological mechanisms of CRSwNP and correlates with disease severity, clinical control, and therapeutic responsiveness. Its dynamic nature allows longitudinal monitoring of inflammatory changes over time, offering insights that complement clinical evaluation and endoscopic assessment. This review integrates current knowledge on epithelial barrier dysfunction and type 2 inflammation with the translational relevance of nasal cytology in CRSwNP. Particular attention is given to its role in disease phenotyping, prognostic stratification, and monitoring of biologic therapies. Within precision medicine frameworks, nasal cytology emerges as a robust cellular biomarker bridging epithelial biology, immune profiling, and personalized clinical decision-making.<\/jats:p>","DOI":"10.3390\/cells15040323","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:07:06Z","timestamp":1770725226000},"page":"323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nasal Cytology as a Cellular Window into Epithelial Dysfunction and Type 2 Inflammation: From Mechanisms to Translational Implications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-0008","authenticated-orcid":false,"given":"Matteo","family":"Gelardi","sequence":"first","affiliation":[{"name":"Unit of Otolaryngology, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"ref_1","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Yang, C., Guo, L., Wang, Y., Jiang, W., Chen, S., and Gu, Q. (2025). The advance on pathophysiological mechanisms of type 2 chronic rhinosinusitis with nasal polyposis. Front. Allergy, 6.","DOI":"10.3389\/falgy.2025.1599797"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1038\/s41598-023-39149-8","article-title":"Eosinophilmast cell pattern of intraepithelial infiltration as a marker of severity in CRSwNP","volume":"13","author":"Gelardi","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/all.16064","article-title":"Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions","volume":"79","author":"Huang","year":"2024","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"uxaf041","DOI":"10.1093\/cei\/uxaf041","article-title":"Thymic stromal lymphopoietin as a therapeutic target in patients with chronic rhinosinusitis and nasal polyps","volume":"219","author":"Peters","year":"2025","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5415\/apallergy.0000000000000228","article-title":"Nasal cytology in the rhinology\u2013allergy clinic: From rhinitis to chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"15","author":"Gelardi","year":"2025","journal-title":"Asia Pac. Allergy"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100700","DOI":"10.1016\/j.waojou.2022.100700","article-title":"Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps","volume":"15","author":"Paoletti","year":"2022","journal-title":"World Allergy Organ J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jaci.2020.04.049","article-title":"The clinical relevance of the clinical\u2013cytological grading in patients with chronic rhinosi-nusitis with nasal polyps","volume":"146","author":"Gelardi","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: An analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Inf. Libr. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/19458924231154061","article-title":"New concepts in barrier dysfunction in CRSwNP and emerging roles of tezepelumab and dupilumab","volume":"37","author":"Chiang","year":"2023","journal-title":"Am. J. Rhinol. Allergy"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41598-024-52341-8","article-title":"Single-cell RNA sequencing reveals the epithelial cell, fibroblast, and key gene alterations in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_14","first-page":"1","article-title":"Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: A change management approach. Consensus of the Joint Committee of the Italian Society of Otorhinolaryngology on biologics in rhinology","volume":"42","author":"Bellocchi","year":"2022","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bagnasco, D., De Ferrari, L., Bondi, B., Candeliere, M.G., Mincarini, M., Riccio, A.M., and Braido, F. (2024). Thymic stromal lymphopoietin and tezepelumab in airway diseases: From physiological role to target therapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115972"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Caruso, C., Giancaspro, R., Guida, G., Macchi, A., Landi, M., Heffler, E., and Gelardi, M. (2022). Nasal cytology: An easy diagnostic tool in precision medicine for inflammation in epithelial barrier damage in the nose. A perspective mini review. Front. Allergy, 3.","DOI":"10.3389\/falgy.2022.768408"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"103447","DOI":"10.1016\/j.amjoto.2022.103447","article-title":"Chronic rhinosinusitis with nasal polyps recurrence: Not only eosinophils and neutrophils","volume":"43","author":"Gelardi","year":"2022","journal-title":"Am. J. Otolaryngol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1535370214553898","article-title":"Isolation and characterization of multipotent mesenchymal stem cells in nasal polyps","volume":"240","author":"Cho","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"de Oliveira, P.W.B., Pezato, R., Henao Agudelo, J.S., Perez-Novo, C.A., Vanden Berghe, W., C\u00e2mara, N.O., de Almeida, D.C., and Gregorio, L.C. (2017). Nasal polypderived mesenchymal stromal cells exhibit lack of immune-associated molecules and high levels of stem\/progenitor cell markers. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00039"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chiarella, E., Lombardo, N., Lobello, N., Aloisio, A., Aragona, T., Pelaia, C., Scicchitano, S., Bond, H.M., and Mesuraca, M. (2020). Nasal polyposis: Insights in epithelial\u2013mesenchymal transition and differentiation of polyp mesenchymal stem cells. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202008.0087.v1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00005-016-0409-7","article-title":"Epithelial\u2013mesenchymal transition in chronic rhinosinusitis: Differences revealed between epithelial cells from nasal polyps and inferior turbinates","volume":"65","author":"Burmeister","year":"2017","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1159\/000524950","article-title":"The role of epithelial\u2013mesenchymal transition in chronic rhinosinusitis","volume":"183","author":"Xia","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_24","first-page":"181","article-title":"Nasalsinus polyposis: Clinical-cytological grading and prognostic index of relapse","volume":"23","author":"Gelardi","year":"2009","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/alr.22780","article-title":"Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps","volume":"11","author":"Hopkins","year":"2021","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/cea.12730","article-title":"NASAL cytology: Practical aspects and clinical relevance","volume":"46","author":"Gelardi","year":"2016","journal-title":"Clin. Exp. Allergy"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Nappi, E., Marzio, V., Giombi, F., Costanzo, G., Merli, S., Nicolosi, S., Cavagli\u00e0, E., Lodi Rizzini, F., Traversi, S., and Vrenna, A. (2025). Chronic rhinosinusitis with and without nasal polyps: The state-of-the-art of current treatment strategies and future developments. Front. Allergy, 6.","DOI":"10.3389\/falgy.2025.1714577"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2500\/ajra.2009.23.3413a","article-title":"Characterization of bacterial and fungal biofilms in chronic rhinosinusitis","volume":"1","author":"Foreman","year":"2010","journal-title":"Allergy Rhinol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Danisman, Z., Linxweiler, M., K\u00fchn, J.P., Linxweiler, B., Solomayer, E.F., Wagner, M., Wagenpfeil, G., Schick, B., and Berndt, S. (2023). Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with dupilumab. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1127576"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European Position Paper on Rhinosinusitis and Nasal Polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"104275","DOI":"10.1016\/j.amjoto.2024.104275","article-title":"Dupilumab\u2019s impact on nasal cytology: Real-life experience after 1 year of treatment","volume":"45","author":"Gelardi","year":"2024","journal-title":"Am. J. Otolaryngol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"989\u2013995.e8","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: Toward precision medicine of chronic airway diseases","volume":"47","author":"Bel","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101058","DOI":"10.1016\/j.waojou.2025.101058","article-title":"ARIA-ITALYPANEL ARIA-Italy multidisciplinary consensus on nasal polyposis and biological treatments: Update 2025","volume":"18","author":"Lombardi","year":"2025","journal-title":"World Allergy Organ J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijmedinf.2018.11.010","article-title":"Nasal cytology with deep learning techniques","volume":"122","author":"Dimauro","year":"2019","journal-title":"Int. J. Med. Inform."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhang, X., Xu, X., Liu, W., Qin, L., Song, Y., Li, J., Xi, L., Wang, C., Zhang, L., and Zhang, Y. (2025). Development of Artificial Intelligence for Quantitative Assessment of Nasal Inflammatory Cytology in Chronic Rhinitis by Whole-Slide Images. Int. Forum Allergy Rhinol., online ahead of print.","DOI":"10.1002\/alr.70075"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5415\/apallergy.0000000000000239","article-title":"Nasal cytology: Cornerstone and future directions in precision nasal disease management","volume":"15","author":"Zhang","year":"2025","journal-title":"Asia Pac. Allergy"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/4\/323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:19:18Z","timestamp":1770725958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/4\/323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["cells15040323"],"URL":"https:\/\/doi.org\/10.3390\/cells15040323","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}